Tapewire

NYSE · USD

MET

METLIFE INC

Export transactions ↓
Tapewire entity
488
SEC CIK
0001099219
Parsed reports
1,091

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 13, 2017 Filed Dec 15, 2017 21:18 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
GrantCommon Stock 1,194.3648 $52.84 $63,110.24
Disclosure

SEC source: 0001209191-17-065911 · doc4.xml · nonDerivative · entry 1

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342,409.9527

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2017 Filed Dec 15, 2017 21:17 UTC GrantCommon Stock 342.7277 $52.84 $18,109.73
Disclosure

SEC source: 0001209191-17-065909 · doc4.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,325.0631

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
December 13, 2017 Filed Dec 15, 2017 21:18 UTC GrantCommon Stock Equivalents · Derivative 135.6774 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-065910 · doc4.xml · derivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135.6774

Underlying: Common Stock · 135.6774 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F2 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
December 13, 2017 Filed Dec 15, 2017 21:18 UTC GrantCommon Stock 297.956 $52.84 $15,744.00
Disclosure

SEC source: 0001209191-17-065910 · doc4.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,435.9485

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 21:23 UTC
Townsend Christopher GPresident, Asia
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 13,106 $0.00 Strike: $34.33 $0.00
Disclosure

SEC source: 0001209191-17-059752 · doc4.xml · derivative · entry 9

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,216

Underlying: Common Stock · 13,106 shares

Expires 2026-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The options became exercisable in three equal installments on February 23, 2017, 2018 and 2019.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 21:23 UTC
Townsend Christopher GPresident, Asia
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 17,425 $0.00 Strike: $45.91 $0.00
Disclosure

SEC source: 0001209191-17-059752 · doc4.xml · derivative · entry 8

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,713

Underlying: Common Stock · 17,425 shares

Expires 2025-02-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The options became exercisable in three equal installments on February 24, 2016, 2017 and 2018.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 21:23 UTC
Townsend Christopher GPresident, Asia
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 25,181 $0.00 Strike: $45.15 $0.00
Disclosure

SEC source: 0001209191-17-059752 · doc4.xml · derivative · entry 7

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,181 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options became exercisable in three equal installments on February 25, 2015, 2016 and 2017.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 21:23 UTC
Townsend Christopher GPresident, Asia
SaleCommon Stock 13,106 $54.20 $710,345.20
Disclosure

SEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 6

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(3) and (4) to this Form 4.

F4 · price: The shares were sold in multiple transactions at prices $54.061 to $54.325, inclusive.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 21:23 UTC
Townsend Christopher GPresident, Asia
Exercise / conversionCommon Stock 13,106 $34.33 $449,928.98
Disclosure

SEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 5

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,106

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 21:23 UTC
Townsend Christopher GPresident, Asia
SaleCommon Stock 17,425 $54.29 $945,985.83
Disclosure

SEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 4

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(3) and (4) to this Form 4.

F3 · price: The shares were sold in multiple transactions at prices $54.225 to $54.370, inclusive.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 21:23 UTC
Townsend Christopher GPresident, Asia
Exercise / conversionCommon Stock 17,425 $45.91 $799,981.75
Disclosure

SEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 3

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 21:23 UTC
Townsend Christopher GPresident, Asia
SaleCommon Stock 25,181 $54.34 $1,368,411.08
Disclosure

SEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 2

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(3) and (4) to this Form 4.

F2 · price: The shares were sold in multiple transactions at prices $54.131 to $54.490, inclusive.

Read SEC document
November 06, 2017 Filed Nov 8, 2017 21:23 UTC
Townsend Christopher GPresident, Asia
Exercise / conversionCommon Stock 25,181 $45.15 $1,136,922.15
Disclosure

SEC source: 0001209191-17-059752 · doc4.xml · nonDerivative · entry 1

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,181

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 21:16 UTC
Townsend Christopher GPresident, Asia
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 33,071 $0.00 Strike: $31.15 $0.00
Disclosure

SEC source: 0001209191-17-059597 · doc4.xml · derivative · entry 6

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,071 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The options became exercisable in three equal installments on February 26, 2014, 2015 and 2016.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 21:16 UTC
Townsend Christopher GPresident, Asia
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 49,660 $0.00 Strike: $27.19 $0.00
Disclosure

SEC source: 0001209191-17-059597 · doc4.xml · derivative · entry 5

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 49,660 shares

Expires 2022-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options became exercisable in three equal installments on August 1, 2013, 2014 and 2015.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 21:16 UTC
Townsend Christopher GPresident, Asia
SaleCommon Stock 33,071 $54.60 $1,805,742.74
Disclosure

SEC source: 0001209191-17-059597 · doc4.xml · nonDerivative · entry 4

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

F3 · price: The shares were sold in multiple transactions at prices $54.600 to $54.618, inclusive.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 21:16 UTC
Townsend Christopher GPresident, Asia
Exercise / conversionCommon Stock 33,071 $31.15 $1,030,161.65
Disclosure

SEC source: 0001209191-17-059597 · doc4.xml · nonDerivative · entry 3

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,071

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 21:16 UTC
Townsend Christopher GPresident, Asia
SaleCommon Stock 49,660 $54.61 $2,711,684.30
Disclosure

SEC source: 0001209191-17-059597 · doc4.xml · nonDerivative · entry 2

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

F2 · price: The shares were sold in multiple transactions at prices $54.560 to $54.630, inclusive.

Read SEC document
November 03, 2017 Filed Nov 7, 2017 21:16 UTC
Townsend Christopher GPresident, Asia
Exercise / conversionCommon Stock 49,660 $27.19 $1,350,255.40
Disclosure

SEC source: 0001209191-17-059597 · doc4.xml · nonDerivative · entry 1

Townsend Christopher G · CIK 0001555359 · President, Asia

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:22 UTC GrantCommon Stock 720 $52.14 $37,540.80
Disclosure

SEC source: 0001209191-17-055827 · doc4.xml · nonDerivative · entry 1

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,324.3467

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:23 UTC GrantCommon Stock 720 $52.14 $37,540.80
Disclosure

SEC source: 0001209191-17-055833 · doc4.xml · nonDerivative · entry 1

MORRISON DENISE M · CIK 0001230166 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,461

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:22 UTC GrantCommon Stock 720 $52.14 $37,540.80
Disclosure

SEC source: 0001209191-17-055831 · doc4.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,237.6473

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:21 UTC GrantCommon Stock 720 $52.14 $37,540.80
Disclosure

SEC source: 0001209191-17-055824 · doc4.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,813.7932

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:20 UTC GrantCommon Stock 720 $52.14 $37,540.80
Disclosure

SEC source: 0001209191-17-055822 · doc4.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,265.976

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:19 UTC GrantCommon Stock 720 $52.14 $37,540.80
Disclosure

SEC source: 0001209191-17-055818 · doc4.xml · nonDerivative · entry 1

KELLY ALFRED F JR · CIK 0001209454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,941.3192

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:19 UTC GrantCommon Stock Equivalent Units · Derivative 479.4783 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-055812 · doc4.xml · derivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 479.4783

Underlying: Common Stock · 479.4783 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock.

F2 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:19 UTC GrantCommon Stock 720 $52.14 $37,540.80
Disclosure

SEC source: 0001209191-17-055812 · doc4.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,137.9924

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:18 UTC GrantCommon Stock 720 $52.14 $37,540.80
Disclosure

SEC source: 0001209191-17-055805 · doc4.xml · nonDerivative · entry 1

Herzog David L · CIK 0001331793 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,512

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:17 UTC GrantCommon Stock 720 $52.14 $37,540.80
Disclosure

SEC source: 0001209191-17-055798 · doc4.xml · nonDerivative · entry 1

GUTIERREZ CARLOS M · CIK 0001185943 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,902

F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 20:16 UTC GrantCommon Stock 720 $52.14 $37,540.80
Disclosure

SEC source: 0001209191-17-055793 · doc4.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,982.3353

F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:24 UTC GrantCommon Stock 192.992 $48.65 $9,389.06
Disclosure

SEC source: 0001209191-17-052974 · doc4.xml · nonDerivative · entry 1

Kinney Catherine R · CIK 0001205054 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,517.6473

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2 · balance_after: Includes 2,503.1114 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:23 UTC GrantCommon Stock Equivalent Units · Derivative 89.6406 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-052971 · doc4.xml · derivative · entry 4

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89.6406

Underlying: Common Stock · 89.6406 shares

Expires not disclosed

F4 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F5 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F4 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:23 UTC GrantCommon Stock 369.6338 $48.65 $17,982.68
Disclosure

SEC source: 0001209191-17-052971 · doc4.xml · nonDerivative · entry 1

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,604.3467

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2 · balance_after: Includes 4,794.1599 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:22 UTC GrantCommon Stock 106.7792 $48.65 $5,194.81
Disclosure

SEC source: 0001209191-17-052968 · doc4.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,093.7932

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2 · balance_after: Includes 1,384.9283 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:21 UTC GrantCommon Stock 69.6919 $48.65 $3,390.51
Disclosure

SEC source: 0001209191-17-052966 · doc4.xml · nonDerivative · entry 1

KELLY EDWARD J III · CIK 0001160225 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,545.976

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2 · balance_after: Includes 903.9065 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:20 UTC GrantCommon Stock 237.3359 $48.65 $11,546.39
Disclosure

SEC source: 0001209191-17-052965 · doc4.xml · nonDerivative · entry 1

KELLY ALFRED F JR · CIK 0001209454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,221.3192

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2 · balance_after: Includes 3,078.2531 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:19 UTC GrantCommon Stock Equivalents · Derivative 142.2508 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-052963 · doc4.xml · derivative · entry 3

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142.2508

Underlying: Common Stock · 142.2508 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:19 UTC GrantCommon Stock 315.1069 $48.65 $15,329.95
Disclosure

SEC source: 0001209191-17-052963 · doc4.xml · nonDerivative · entry 1

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,417.9924

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2 · balance_after: Includes 4,086.9453 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:18 UTC GrantCommon Stock 363.3381 $48.65 $17,676.40
Disclosure

SEC source: 0001209191-17-052961 · doc4.xml · nonDerivative · entry 1

GRISE CHERYL W · CIK 0001192342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,262.3353

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2 · balance_after: Includes 4,712.5043 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:17 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
GrantCommon Stock 1,286.6511 $48.65 $62,595.58
Disclosure

SEC source: 0001209191-17-052959 · doc4.xml · nonDerivative · entry 1

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,215.5879

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2 · balance_after: Includes 16,687.8966 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares.

Read SEC document
September 13, 2017 Filed Sep 15, 2017 20:18 UTC
Morris Maria REVP, Global Employee Benefits
GrantCommon Stock 322.6171 $48.65 $15,695.32
Disclosure

SEC source: 0001209191-17-052960 · doc4.xml · nonDerivative · entry 1

Morris Maria R · CIK 0001423154 · EVP, Global Employee Benefits

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,278.9192

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral accounts pursuant to the MetLife Deferred Compensation Plan for Officers and the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2 · balance_after: Includes 4,184.3515 Deferred Shares previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Deferred Shares in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Deferred Shares.

Read SEC document
September 11, 2017 Filed Sep 13, 2017 20:18 UTC
TADROS RAMYEVP & Chief Risk Officer
GrantRestricted Stock Units · Derivative 34,377 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-052591 · doc4.xml · derivative · entry 1

TADROS RAMY · CIK 0001714199 · EVP & Chief Risk Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,377

Underlying: Common Stock · 34,377 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.

F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.

F2 · derivative.exercise_date: The award of Restricted Stock Units will "cliff vest" on September 11, 2020 and will be payable 100% in shares.

F2 · derivative.expiration_date: The award of Restricted Stock Units will "cliff vest" on September 11, 2020 and will be payable 100% in shares.

Read SEC document
August 07, 2017 Filed Sep 15, 2017 20:23 UTC GrantCommon Stock Equivalent Units · Derivative 1,162.642 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-052971 · doc4.xml · derivative · entry 3

KILTS JAMES M · CIK 0001025094 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,162.642

Underlying: Common Stock · 1,162.642 shares

Expires not disclosed

F4 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F5 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F4 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F6 · balance_after: Common Stock Equivalents previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Common Stock Equivalents in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Common Stock Equivalents.

Read SEC document
August 07, 2017 Filed Sep 15, 2017 20:19 UTC GrantCommon Stock Equivalents · Derivative 1,844.9973 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-052963 · doc4.xml · derivative · entry 2

HUBBARD ROBERT GLENN · CIK 0001283051 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,844.9973

Underlying: Common Stock · 1,844.9973 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F4 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units.

F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments.

F5 · balance_after: Common Stock Equivalents previously added to the reporting person's ownership through an adjustment to maintain the intrinsic value of Common Stock Equivalents in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of Common Stock Equivalents.

Read SEC document
July 10, 2017 Filed Jul 11, 2017 20:18 UTC
PODLOGAR SUSAN MEVP & Chief HR Officer
GrantRestricted Stock Units · Derivative 26,762 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-044772 · doc4.xml · derivative · entry 1

PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,762

Underlying: Common Stock · 26,762 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.

F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock.

F2 · derivative.exercise_date: The award of Restricted Stock Units will "cliff vest" on July 10, 2020 and will be payable 100% in shares.

F2 · derivative.expiration_date: The award of Restricted Stock Units will "cliff vest" on July 10, 2020 and will be payable 100% in shares.

Read SEC document
June 13, 2017 Filed Jun 15, 2017 20:22 UTC GrantCommon Stock 704 $53.31 $37,530.24
Disclosure

SEC source: 0001209191-17-040137 · doc4.xml · nonDerivative · entry 2

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,602.0857

F2 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
June 13, 2017 Filed Jun 15, 2017 20:22 UTC GrantCommon Stock 81.1624 $53.31 $4,326.77
Disclosure

SEC source: 0001209191-17-040137 · doc4.xml · nonDerivative · entry 1

Kennard William E · CIK 0001198236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,898.0857

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
June 13, 2017 Filed Jun 15, 2017 20:21 UTC GrantCommon Stock 704 $53.31 $37,530.24
Disclosure

SEC source: 0001209191-17-040132 · doc4.xml · nonDerivative · entry 2

KELLY ALFRED F JR · CIK 0001209454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,905.7302

F2 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time.

Read SEC document
June 13, 2017 Filed Jun 15, 2017 20:21 UTC GrantCommon Stock 192.6251 $53.31 $10,268.84
Disclosure

SEC source: 0001209191-17-040132 · doc4.xml · nonDerivative · entry 1

KELLY ALFRED F JR · CIK 0001209454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,201.7302

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

Read SEC document
June 13, 2017 Filed Jun 15, 2017 20:26 UTC
KANDARIAN STEVEN ADirector · Chairman, President & CEO
GrantCommon Stock 1,041.1546 $53.31 $55,503.95
Disclosure

SEC source: 0001209191-17-040146 · doc4.xml · nonDerivative · entry 1

KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,241.0402

F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.

F2 · balance_after: Includes 51,000 shares previously reported as indirectly beneficially owned through a Grantor Retained Annuity Trust ("GRAT").

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.